The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development

被引:17
|
作者
Balasegaram, Manica [1 ]
Piddock, Laura J. V. [1 ]
机构
[1] Global Antibiot Res & Dev Partnership GARDP, CH-1202 Geneva, Switzerland
来源
ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 06期
关键词
D O I
10.1021/acsinfecdis.0c00101
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP's recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
引用
收藏
页码:1295 / 1298
页数:4
相关论文
共 50 条